Pooled analysis of post-progression treatments after first-line ribociclib plus endocrine therapy in patients with HR+/HER2-advanced breast cancer in the MONALEESA-2,-3, and-7 studies
CANCER RESEARCH（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要